Immunogenicity and safety study of GlaxoSmithKline Biologicals’ Infanrix hexa™ vaccine in healthy infants in India

Update Il y a 4 ans
Reference: EUCTR2013-003427-10

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the immunological response to the study vaccine in terms of seroprotection status for diphtheria, tetanus, polio, hepatitis B (HB) and Haemophilus influenza type b (Hib) anti-gens, and in terms of vaccine response for the pertussis (PT) antigens, one month after the third dose of the primary vacci-nation.


Inclusion criteria

  • Primary immunisation of healthy infants in the first year of life against diphtheria, tetanus, pertussis, hepatitis B, polio and Hib diseases